bf/NASDAQ:CHRS_icon.jpeg

COM:COHERUS

Coherus BioSciences

  • Stock

Last Close

1.10

22/11 21:00

Market Cap

164.06M

Beta: -

Volume Today

2.69M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.75M
-
31.11M
1,030.72%
30.04M
3.42%
190.11M
532.82%
1.56M
99.18%
1.56M
0%
356.07M
22,783.74%
475.82M
33.63%
326.55M
31.37%
211.04M
35.37%
257.24M
21.89%
cost of revenue
17.08M
-
37.67M
120.56%
57.59M
52.90%
70.08M
21.69%
162.78M
132.27%
gross profit
2.75M
-
31.11M
1,030.72%
30.04M
3.42%
190.11M
532.82%
1.56M
99.18%
1.56M
0%
338.99M
21,686.18%
438.16M
29.25%
268.96M
38.62%
140.96M
47.59%
94.46M
32.99%
selling and marketing expenses
general and administrative expenses
7.46M
-
17.56M
135.28%
36.05M
105.23%
51.60M
43.14%
71.30M
38.19%
94.18M
32.08%
selling general and administrative expenses
7.46M
-
17.56M
135.28%
36.05M
105.23%
51.60M
43.14%
71.30M
38.19%
94.18M
32.08%
137.04M
45.51%
139.08M
1.49%
169.71M
22.03%
198.48M
16.95%
185.62M
6.48%
research and development expenses
31.28M
-
78.22M
150.08%
213.06M
172.37%
254.44M
19.42%
162.39M
36.18%
110.24M
32.11%
94.19M
14.56%
142.76M
51.57%
363.11M
154.35%
199.36M
45.10%
102.05M
48.81%
other expenses
-12.35M
-
-18.59M
50.58%
-4.84M
73.98%
-3.88M
19.86%
3.40M
187.75%
4.69M
37.89%
2.61M
44.40%
554K
78.76%
-283K
151.08%
3.82M
1,450.53%
5.47M
43.09%
cost and expenses
38.74M
-
95.79M
147.23%
249.11M
160.06%
306.04M
22.85%
233.69M
23.64%
204.42M
12.53%
248.30M
21.47%
319.50M
28.68%
590.41M
84.79%
467.92M
20.75%
450.44M
3.74%
operating expenses
38.74M
-
95.79M
147.23%
249.11M
160.06%
306.04M
22.85%
233.69M
23.64%
204.42M
12.53%
231.22M
13.11%
281.84M
21.89%
532.82M
89.05%
397.84M
25.33%
287.66M
27.69%
interest expense
5.29M
-
3.90M
26.32%
33K
99.15%
7.98M
24,081.82%
9.55M
19.70%
9.68M
1.38%
17.60M
81.75%
21.17M
20.25%
22.96M
8.47%
32.47M
41.44%
40.54M
24.84%
ebitda
-47.94M
-
-83.28M
73.72%
-223.91M
168.87%
-119.81M
46.49%
-228.73M
90.92%
-199.72M
12.68%
110.38M
155.26%
156.87M
42.13%
-264.14M
268.38%
-253.06M
4.20%
-189.41M
25.15%
operating income
-35.99M
-
-64.68M
79.71%
-219.07M
238.68%
-115.93M
47.08%
-232.14M
100.24%
-204.42M
11.94%
107.77M
152.72%
156.32M
45.05%
-263.86M
268.79%
-256.88M
2.64%
-193.20M
24.79%
depreciation and amortization
404K
-
674K
66.83%
1.87M
177.30%
3.00M
60.30%
3.40M
13.42%
3.23M
4.80%
2.61M
19.38%
554K
78.76%
-283K
151.08%
3.82M
1,450.53%
3.79M
0.81%
total other income expenses net
-12.35M
-
-18.59M
50.58%
-4.84M
73.98%
-3.88M
19.86%
3.40M
187.75%
4.69M
37.89%
-14.99M
419.61%
-20.61M
37.48%
-23.24M
12.76%
-34.87M
50.05%
-45.07M
29.25%
income before tax
-53.63M
-
-87.18M
62.54%
-223.94M
156.88%
-127.79M
42.94%
-238.29M
86.47%
-209.41M
12.12%
92.78M
144.30%
135.71M
46.28%
-287.10M
311.56%
-291.75M
1.62%
-238.27M
18.33%
income tax expense
-7.06M
-
-15.41M
118.44%
-7.35M
52.30%
656K
108.92%
9.44M
1,339.02%
4.69M
50.31%
2.94M
37.28%
3.46M
17.71%
19.22M
455.07%
34.87M
81.43%
-380K
101.09%
net income
-53.63M
-
-87.13M
62.46%
-223.26M
156.23%
-127.34M
42.96%
-238.17M
87.04%
-209.34M
12.11%
89.83M
142.91%
132.24M
47.21%
-306.32M
331.63%
-326.63M
6.63%
-237.89M
27.17%
weighted average shs out
18.08M
-
8.19M
54.73%
37.12M
353.45%
41.91M
12.90%
53.13M
26.77%
65.03M
22.40%
69.68M
7.14%
71.41M
2.49%
75.45M
5.65%
77.63M
2.89%
94.16M
21.30%
weighted average shs out dil
18.08M
-
8.19M
54.73%
37.12M
353.45%
41.91M
12.90%
53.13M
26.77%
65.03M
22.40%
73.19M
12.53%
83.49M
14.08%
75.45M
9.63%
77.63M
2.89%
94.16M
21.30%
eps
-2.97
-
-10.64
258.25%
-6.01
43.52%
-3.04
49.42%
-4.48
47.37%
-3.22
28.13%
1.29
140.06%
1.85
43.41%
-4.06
319.46%
-4.21
3.69%
-2.53
39.90%
epsdiluted
-2.97
-
-10.64
258.25%
-6.01
43.52%
-3.04
49.42%
-4.48
47.37%
-3.22
28.13%
1.23
138.20%
1.62
31.71%
-4.06
350.62%
-4.21
3.69%
-2.53
39.90%

All numbers in (except ratios and percentages)